AMC vs NMAX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals severe financial distress with a Piotroski F-Score of just 1/9, indicating extremely weak fundamental health. Despite some recent improvements in earnings surprises and short-term growth metrics, the company remains unprofitable with negative margins, a deteriorating balance sheet, and deeply negative valuation multiples. Liquidity is critically constrained with a current ratio of 0.39 and a quick ratio of 0.29, raising serious solvency concerns. The stock's technical trend is bearish, insider sentiment is neutral, and long-term price performance shows a catastrophic 96.5% decline over five years, far underperforming peers in the Communication Services sector.
NMAX exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. Despite maintaining a low debt-to-equity ratio and acceptable liquidity, the company is suffering from severe profitability collapse with an ROE of -205.18% and a profit margin of -52.57%. The stock has experienced a catastrophic long-term decline, losing 92.5% of its value over five years. While analyst target prices suggest a significant upside, the deterministic data points to a high-risk profile with no current evidence of a sustainable turnaround.
Compare Another Pair
Related Comparisons
AMC vs NMAX: Head-to-Head Comparison
This page compares AMC Entertainment Holdings, Inc. (AMC) and Newsmax, Inc. (NMAX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.